Thrombocytopenia among patients with vivax-positive malaria. | [Professional Medical Journal • 2023]

Author(s):

1. Muhamamd Salman Aamir: Fellowship Diabetes & Endocrinology, Consultant Physician, Hayatabad Medical, complex Pakistan

2. Muhammad Ali: Hayatabad Medical Complex, Peshawar, Pakistan

3. Muhammad Bilal Khattak: Kidney Center Hospital, Havelian.Pakistan

4. Siraj ul Islam: Hayatabad Medical Complex, Peshawar.Pakistan

5. Afrasyab Khalil: Hayatabad Medical Complex, Peshawar.Pakistan

6. Shafiullah Khan: DHQ Hospital, Kohat.Pakistan

Abstract:

Objective: To estimate the frequency of thrombocytopenia among patients with vivax-positive malaria. Study Design: Cross Sectional Study. Setting: Department of General Medicine Hayatabad Medical Complex Peshawar. Period: May 2022 to November 2022. Material & Methods: Total 140 cohort were observed in this study. Patients were taken as sample according to inclusion and exclusion criteria as per operational definition after the patients' written informed consent. Sociodemographic data was collected on a predesigned questionnaire. History such as febrile illnesses and blood dyscrasias and basic studies and peripheral blood smears were obtained. Results: The results of the study showed the sample has mean age 36 years with SD ± 3.72, of which 70% were men while 30% were women. Thrombocytopenia was observed in 68% of patients. Conclusion: In conclusion, the estimated frequency of thrombocytopenia in vivax malaria was found to be 68%.

Page(s): 622-625

DOI: 10.29309/TPMJ/2023.30.05.7367

Published: Journal: Professional Medical Journal, Volume: 30, Issue: 5, Year: 2023

Keywords:

malaria , malaria , thrombocytopenia , Vivax

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views